IndiaTechDesk - India's Leading Tech and Startup Media Publication
  • Home
  • TOPICS
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Business
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Ecosystem & Lists
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • Investments
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • enterprise
    • SaaS
    • Venture capital
  • Interviews
  • Events
No Result
View All Result
  • Home
  • TOPICS
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Business
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Ecosystem & Lists
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • Investments
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • enterprise
    • SaaS
    • Venture capital
  • Interviews
  • Events
No Result
View All Result
IndiaTechDesk - India's Leading Tech and Startup Media Publication
No Result
View All Result
Home Health & Bio

Eyestem Raises Series A Round to Develop a Cure for Rare Eye Ailment

IndiaTechDesk Editor by IndiaTechDesk Editor
August 10, 2022
in Health & Bio
55 3
0
Eyestem Raises Series A Round to Develop a Cure for Rare Eye Ailment
189
SHARES
1.5k
VIEWS
Share on FacebookShare on Twitter

Eyestem, a Bengaluru-based cell therapy startup, has raised $6.4 million in a Series A round led by three pharma majors, Biological E. Limited (BE), Alkem, NATCO, and Kemwell Biopharma promoters Anurag and Karan Bagaria.

Endiya Partners and Kotak Private Equity, both existing investors, also participated in the round, valuing Eyestem at $46.4 million post-money.

Dr. Jogin Desai, Founder and Chief Executive Officer of Eyestem, said, “We started Eyestem with the sole purpose of being able to create cell therapy products at scale for diseases that devastate a large number of people in India and the world.”

“The support of major Indian pharma companies who share our vision endorses our strategy of developing affordable innovation for patients worldwide. Post this funding, and we will remain focussed on solidifying our cell therapy platform and moving our flagship product for Dry AMD through early clinical trials of an international standard,” he added.

The startup aims to provide vision to patients suffering from rare eye conditions

The company’s patented flagship product, Eyecyte-RPE, is an experimental treatment for Dry Age-Related Macular Degeneration (Dry AMD), and the company has other products in the pipeline for the treatment of incurable diseases affecting humanity.

EyeCyte-RPE replaces damaged retinal pigment epithelium cells and is intended to restore sight in patients in the early stages of Macular Degeneration or to halt vision loss in those in the later stages. The product is allogenic, is administered surgically, and is patented in India and abroad.

In consultation with CDSCO and the US FDA, the company plans to file for a first-in-human trial of the product within a year.

Rajeev Nannapaneni, CEO of NATCO Pharma Limited, said, “We are delighted to be associated with Eyestem for their innovative work that services unmet needs of patients that have a high impact on quality of life.”

Eyestem, founded in 2016 by an experienced team of clinical research, regenerative medicine, and ophthalmology experts, has formed partnerships with other leaders in related scientific disciplines in India, the United Kingdom, Japan, and the United States.

The startup’s long-term goal is to create a scalable cell therapy platform to treat incurable diseases and democratize global access to these newer technologies.

Dr. Ramesh Byrapaneni, the Managing Partner of Endiya Partners, said, “Endiya partners are delighted to back the startup and participate in the current funding round. Adding leading pharma and biotech investors to our cap table is a great validation of the world-class science Eyestem is pursuing, which can change millions of lives globally.”

Tags: fundinghealthcareHealthTechindian startupTiger Global
IndiaTechDesk Editor

IndiaTechDesk Editor

IndiaTechDesk is part of beSUCCESS Media group, focusing on Indian startup and tech news, trends and analysis. Write to us at [email protected]

Related Posts

Healthcare Ed-tech Startup Virohan bags $7 million to Fuel India Expansion
Education

Healthcare Ed-tech Startup Virohan bags $7 million to Fuel India Expansion

January 9, 2023
The Whole Truth Raises $11 million in Series B Funding Round
Health & Bio

The Whole Truth Raises $11 million in Series B Funding Round

December 29, 2022
Gurugram-based Pet Care Startup Vetic Bags $3.7 million to Fuel Expansion
Health & Bio

Gurugram-based Pet Care Startup Vetic Bags $3.7 million to Fuel Expansion

November 30, 2022
Diabetes Care Platform BeatO Bags $33 million in its Series B
Health & Bio

Diabetes Care Platform BeatO Bags $33 million in its Series B

November 16, 2022
Molbio Diagnostic Turns Unicorn After $85 million Infusion from Temasek
Health & Bio

Molbio Diagnostic Turns Unicorn After $85 million Infusion from Temasek

October 1, 2022
AI-based Life science platform Elucidata Raised $16 million in its Series A
Health & Bio

AI-based Life science platform Elucidata Raised $16 million in its Series A

October 1, 2022
No Result
View All Result

Follow Us

FREE NEWSLETTER

 




PRODUCTS

ABOUT US

IndiaTechDesk is obsessed with the Indian startup ecosystem, offering intelligent, engaging coverage of the innovations, emerging startups, and entrepreneurship in India.....read more

MORE FROM OUR NETWORK


  • ktd

  • atd

  • itd

  • ktt

  • kgd

  • kpp

  • ktp

  • kpoppost

  • ustechtimes
Categories
  • Accelerator
  • AI & Big Data
  • AR & VR
  • Bitcoin
  • Blockchain
  • Business
  • Clean Technology
  • Competitions
  • Content & Games
  • Coronavirus
  • Cryptocurrency
  • Cybersecurity
  • E-commerce
  • Ecosystem & Lists
  • Education
  • enterprise
  • Enterprise & SaaS
  • entertainment
  • Events
  • featured
  • FinTech
  • Gadgets & Electronics
  • Gaming
  • Guide
  • Health & Bio
  • Incubator
  • Indian Startups
  • Indian Women
  • Insurance
  • Interviews
  • Investments
  • IoT
  • Manufacturing
  • Market
  • Marketplaces & E-commerce
  • Regulation
  • Robotics
  • SaaS
  • Space Startup
  • Transportation & Logistics
  • Travel
  • Uncategorized
  • Venture capital
  • “Contact: [email protected]”
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • About Us

Copyright © 2023 indiatechdesk.com

No Result
View All Result
  • Contact Us
  • Homepages
  • Business
  • Guide

Copyright © 2023 indiatechdesk.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In